Reporting of Safety Events during Anti-VEGF Treatment: Pharmacovigilance in a Noninterventional Trial

MLA

Focke Ziemssen, et al. “Reporting of Safety Events during Anti-VEGF Treatment: Pharmacovigilance in a Noninterventional Trial.” Journal of Ophthalmology, vol. 2020, Jan. 2020. EBSCOhost, https://doi.org/10.1155/2020/8652370.

APA

Focke Ziemssen, Thomas Hammer, Matthias Grueb, Bettina Mueller, Hüsnü Berk, Maria-Andreea Gamulescu, Jessica Voegeler, Joachim Wachtlin, & OCEAN Study Group. (2020). Reporting of Safety Events during Anti-VEGF Treatment: Pharmacovigilance in a Noninterventional Trial. Journal of Ophthalmology, 2020. https://doi.org/10.1155/2020/8652370

Chicago

Focke Ziemssen, Thomas Hammer, Matthias Grueb, Bettina Mueller, Hüsnü Berk, Maria-Andreea Gamulescu, Jessica Voegeler, Joachim Wachtlin, and OCEAN Study Group. 2020. “Reporting of Safety Events during Anti-VEGF Treatment: Pharmacovigilance in a Noninterventional Trial.” Journal of Ophthalmology 2020 (January). doi:10.1155/2020/8652370.